HOW NON-REFERRAL OUTPATIENT CO-PAYMENT IN TAIWAN IMPACTS ON PATIENTS' OUT-OF-POCKET COSTS AND PRESCRIPTION PATTERNS

Author(s)

Li-Chia Chen, PhD, Assistant Professor1, Ellen Schafheutle, PhD, Research Fellow2, Peter Noyce, PhD, Professor of Pharmacy Practice2, Yen-Hsia Wen, PhD, Assistant Professor1, Jin-Song Wu, MSc, Manager Second Medical Expenditure Section31Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 2 University of Manchester, Manchester, United Kingdom; 3 Bureau of National Health Insurance, Kaohsiung, Taiwan

OBJECTIVES To deter non-essential visits and encourage initial contact in primary care, Taiwan's National Health Insurance's (NHI) implemented a differential co-payment policy on July 15, 2005. A previous study has examined the impact of this policy on medical utilization and total cost to NHI using a regional reimbursement dataset. This study aimed to explore the impact of this policy on outpatient co-payment and prescription patterns across different co-payment groups and tiers of medical facilities. METHODS A segmented time-series analysis on regional weekly outpatient medical claims (January 2004 to July 2006). Outcome variables for co-payment and prescription patterns were stratified by tiers of medical facilities and co-payment groups. Analysis used the auto-regressive integrated moving-average model in STATA 9.0. RESULTS Despite the decrease in outpatient visits, the overall co-payment to patients increased by 1.2% after policy implementation and also increased in most medical facilities (4.8% to 17.9%). Number of general prescriptions decreased across different medical facilities; the average cost and duration per general prescription decreased in medical centers and regional hospitals. The number of continuous prescriptions did not change, except for non-significant decreases in medical centers and regional hospitals. There was an increase in the number of continuous prescriptions dispensed in pharmacies (7.0%). CONCLUSIONS The police significantly increased patients' out-of-pocket payment for outpatient visits. In response to the policy, physicians might prescribe more expensive drugs and extend prescription duration to help patients get the most benefit from the co-payment, and physician in medical centers are more likely to prescribe continuous prescriptions for patients with stable chronic diseases. Further research needs to identify vulnerable subgroups in obtaining necessary treatment, and to explore the impacts of cost-saving strategies on patients' quality of medical care.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PHP12

Topic

Economic Evaluation, Health Policy & Regulatory, Health Service Delivery & Process of Care

Topic Subcategory

Approval & Labeling, Cost/Cost of Illness/Resource Use Studies, Health Care Research, Health Disparities & Equity, Prescribing Behavior, Pricing Policy & Schemes, Reimbursement & Access Policy

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×